Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The interleukin-31 receptor (IL-31R) is a heterodimeric cell surface receptor complex composed of IL-31RA and OSMRβ. It is the functional signaling unit for interleukin 31 (IL-31). Upon IL-31 binding, the JAK/STAT, PI3K/AKT, and MAPK pathways are activated, mediating various cellular responses including inflammation and pruritus. The receptor is expressed on epithelial cells, sensory neurons, and immune cells, and is implicated in atopic dermatitis, other chronic skin diseases, inflammatory bowel disease, airway hypersensitivity disorders, and cancer.
JAK/STAT pathway activation, PI3K/AKT pathway activation, MAPK cascade activation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-31 receptor (IL-31R).